;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • SQI Diagnostics completes private placement of units

    SQI Diagnostics Inc. (TSX-V:SQD), Toronto, Ontario Business: Diagnostic Date completed: 4/10/14 Type: Private placement of units Raised: C$4.2 million ($3.8 million) Units: 8.4 million Price: C$0.50 (unit) Shares after …

    Published on 4/21/2014
  • Vital Therapies completes IPO

    Vital Therapies Inc. (NASDAQ:VTL), San Diego, Calif. Business: Hepatic Date completed: 4/16/14 Type: IPO Raised: $54 million Shares: 4.5 million Price: $12 Shares after offering: 21.1 million Underwriters: BofA Merrill …

    Published on 4/21/2014
  • Wilson Therapeutics completes venture financing

    Wilson Therapeutics AB, Stockholm, Sweden Business: Endocrine/Metabolic Date completed: 4/16/14 Type: Venture financing Raised: Not disclosed Investors: Abingworth Management; MVM Life Science Partners; HealthCap Note: …

    Published on 4/21/2014
  • Zafgen completes debt financing

    Zafgen Inc., Cambridge, Mass. Business: Endocrine/Metabolic Date completed: 4/17/14 Type: Debt financing Raised: $7.5 million Investors: Oxford Finance; MidCap Financial Note: Zafgen drew down $7.5 million from its new,…

    Published on 4/21/2014
  • Relypsa financial update

    Relypsa Inc. (NASDAQ:RLYP), Redwood City, Calif. Business: Endocrine/Metabolic Date announced: 4/16/14 Relypsa raised $13.2 million through the sale of 538,775 shares at $24.50 to cover the overallotment from its April …

    Published on 4/21/2014
  • The Column Group financial update

    The Column Group, San Francisco, Calif. Business: Finance Date announced: 4/11/14 Biotech VC firm The Column Group has raised $175.9 million of a planned $250 million for its second fund, according to an SEC filing. The…

    Published on 4/21/2014
  • Angion proposes IPO

    Angion Biomedica Corp., Uniondale, N.Y. Business: Renal, Pulmonary Date announced: 4/14/14 Type: IPO To be raised: Up to $34.5 million Shares: TBD Price: TBD Underwriter: Aegis Capital Note: The company is seeking to …

    Published on 4/21/2014
  • Synta proposes private placement

    Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Lexington, Mass. Business: Cancer, Autoimmune Date announced: 4/14/14 Type: Private placement To be raised: Up to $5 million Shares: 1.3 million Price: $4.01 Shares outstanding…

    Published on 4/21/2014
  • Vyrix Pharmaceutical proposes IPO

    Vyrix Pharmaceutical Inc., Greenwood Village, Colo. Business: Endocrine/Metabolic Date announced: 4/16/14 Type: IPO To be raised: Up to $28.8 million Shares: TBD Price: TBD Underwriters: Aegis Capital; Fordham Financial…

    Published on 4/21/2014
  • Zafgen proposes IPO

    Zafgen Inc., Cambridge, Mass. Business: Endocrine/Metabolic Date announced: 4/18/14 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: Leerink Partners; Cowen; Canaccord; JMP Securities …

    Published on 4/21/2014
  • Foundation Medicine withdraws follow-on

    Foundation Medicine Inc. (NASDAQ:FMI), Cambridge, Mass. Business: Pharmacogenetics Date announced: 4/15/14 Type: Follow-on Underwriters: JPMorgan; Goldman Sachs Note: Foundation Medicine withdrew its follow-on, citing …

    Published on 4/21/2014
  • Cynapsus amends private placement of units

    Cynapsus Therapeutics Inc. (TSX:CTH), Toronto, Ontario Business: Drug delivery, Neurology Date announced: 4/8/14 Type: Private placement of units To be raised: Up to C$25 million ($22.8 million) Units: 38.5 million …

    Published on 4/14/2014
  • Vital Therapies amends IPO

    Vital Therapies Inc., San Diego, Calif. Business: Hepatic Date announced: 4/7/14 Type: IPO To be raised: Up to $63 million Shares: 4.5 million Price: $13-$15 Underwriters: BofA Merrill Lynch; Credit Suisse; William …

    Published on 4/14/2014
  • Adamas Pharmaceuticals completes IPO

    Adamas Pharmaceuticals Inc. (NASDAQ:ADMS), Emeryville, Calif. Business: Neurology, Infectious Date completed: 4/9/14 Type: IPO Raised: $48 million Shares: 3 million Price: $16 Shares after offering: 16.4 million …

    Published on 4/14/2014
  • Adaptive Biotechnologies completes venture financing

    Adaptive Biotechnologies Corp., Seattle, Wash. Business: Bioinformatics Date completed: 4/7/14 Type: Venture financing Raised: $20 million Investors: Viking Global Investors; individual investors Note: Adaptive said it …

    Published on 4/14/2014
  • Adaptive Biotechnologies completes venture financing

    Adaptive Biotechnologies Corp., Seattle, Wash. Business: Bioinformatics Date completed: 4/7/14 Type: Venture financing Raised: $100 million Investor: Viking Global Investors Note: The financing is a series D round.

    Published on 4/14/2014
  • AdvanDx completes venture financing

    AdvanDx Inc., Woburn, Mass. Business: Diagnostic Date completed: 4/8/14 Type: Venture financing Raised: $9 million Investors: Merck Global Health Innovation Fund; SLS Invest; LD Pension Fund Note: The company raised $9 …

    Published on 4/14/2014
  • Alios completes venture financing

    Alios BioPharma Inc., South San Francisco, Calif. Business: Infectious Date completed: 4/7/14 Type: Venture financing Raised: $41 million Investors: Novo Ventures; SR One; Roche Venture Fund; Novartis Venture Funds; and…

    Published on 4/14/2014
  • Assembly completes venture financing

    Assembly Pharmaceuticals Inc., San Francisco, Calif. Business: Infectious Date completed: 4/10/14 Type: Venture financing Raised: Not disclosed. Investors: Luson Bioventures; BioCrossroads; Johnson & Johnson Development…

    Published on 4/14/2014
  • Cerulean completes IPO

    Cerulean Pharma Inc. (NASDAQ: CERU), Cambridge, Mass. Business: Drug delivery, Cancer Date completed: 4/10/14 Type: IPO Raised: $59.5 million Shares: 8.5 million Price: $7 Shares after offering: 19 million Underwriters:…

    Published on 4/14/2014
  • Cyclacel completes follow-on

    Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC), Berkeley Heights, N.J. Business: Cancer Date completed: 4/4/14 Type: Follow-on Raised: $10 million Shares: 2.9 million Price: $3.50 Shares after offering: 22.7 million …

    Published on 4/14/2014
  • Genomind completes venture financing

    Genomind LLC, Chalfont, Pa. Business: Neurology Date completed: 4/9/14 Type: Venture financing Raised: $5 million Investor: Claritas Capital

    Published on 4/14/2014
  • kaleo completes venture financing

    kaleo Inc., Richmond, Va. Business: Drug delivery Date completed: 4/7/14 Type: Venture financing Raised: $150 million Investor: PDL BioPharma Inc. Note: The notes bear 13% interest and mature in March 2029. The notes …

    Published on 4/14/2014
  • Kindred Biosciences completes IPO

    Kindred Biosciences Inc. (NASDAQ:KIN), Burlingame, Calif. Business: Veterinary Date completed: 4/3/14 Type: IPO Raised: $62.1 million Shares: 3.5 million Price: $18 Shares after offering: 19.7 million Underwriters: …

    Published on 4/14/2014
  • Neptune Technologies completes private placement

    Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT; TSX:NTB), Laval, Quebec Business: Nutraceuticals, Cardiovascular, Neurology Date completed: 4/4/14 Type: Private placement Raised: C$2.5 million ($2.3 million) …

    Published on 4/14/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993